Albarico, Ermie R.

HRN: 21-47-53  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/20/2026
04/20/2026
IV
4.45
Q8
Sespsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines